Integrated BioPharma Overview
- Year Founded
-
1979
- Status
-
Public
- Employees
-
134
- Stock Symbol
-
INBP
- Investments
-
1
- Share Price
-
$0.17
- (As of Monday Closing)
Integrated BioPharma General Information
Description
Integrated Biopharma Inc is engaged in the business of manufacturing, distributing, marketing and selling vitamins, nutritional supplements and herbal products. The company's customers are located in the United States and Luxembourg. Its business segments include: Contract Manufacturing which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers and Other Business Lines which includes the operations of MDC Warehousing and Distribution, Inc., a service provider for warehousing and fulfillment services, Chem International, Inc, a distributor of certain raw materials for DSM Nutritional Products LLC and the holding entity of the company and all other inactive subsidiaries of the company.
Contact Information
Website
www.ibiopharma.comCorporate Office
- 225 Long Avenue
- Building 15
- Hillside, NJ 07205
- United States
Corporate Office
- 225 Long Avenue
- Building 15
- Hillside, NJ 07205
- United States
Integrated BioPharma Stock Performance
As of 16-Nov-2026, Integrated BioPharma’s stock price is $0.17. Its current market cap is $5.44M with 31.1M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.17 | $0.17 | $0.14 - $0.42 | $5.44M | 31.1M | 13.4K | -$0.09 |
Integrated BioPharma Financials Summary
As of 30-Jun-2026, Integrated BioPharma has a trailing 12-month revenue of $43.9M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 3,101 | 3,101 | 8,992 | 6,340 |
| Revenue | 43,872 | 43,872 | 54,353 | 50,317 |
| EBITDA | (1,329) | (1,329) | 3,292 | 1,471 |
| Net Income | (2,842) | (2,842) | 808 | 112 |
| Total Assets | 25,338 | 25,338 | 24,901 | 26,207 |
| Total Debt | 3,078 | 3,078 | 1,015 | 1,798 |
Integrated BioPharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Integrated BioPharma Signals
Integrated BioPharma Acquisitions (1)
Integrated BioPharma’s most recent deal was a Merger/Acquisition with BevSpec. The deal was made on 07-Mar-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BevSpec | 07-Mar-2007 | Merger/Acquisition | Beverages |
Integrated BioPharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Integrated BioPharma Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Iht Health Products | Hillside, NJ | 2000 | |
| Agrolabs (Hillside) | Hillside, NJ | 1992 |
Integrated BioPharma FAQs
-
When was Integrated BioPharma founded?
Integrated BioPharma was founded in 1979.
-
Where is Integrated BioPharma headquartered?
Integrated BioPharma is headquartered in Hillside, NJ.
-
What is the size of Integrated BioPharma?
Integrated BioPharma has 134 total employees.
-
What industry is Integrated BioPharma in?
Integrated BioPharma’s primary industry is Pharmaceuticals.
-
Is Integrated BioPharma a private or public company?
Integrated BioPharma is a Public company.
-
What is Integrated BioPharma’s stock symbol?
The ticker symbol for Integrated BioPharma is INBP.
-
What is the current stock price of Integrated BioPharma?
As of 16-Nov-2026 the stock price of Integrated BioPharma is $0.17.
-
What is the current market cap of Integrated BioPharma?
The current market capitalization of Integrated BioPharma is $5.44M.
-
What is Integrated BioPharma’s current revenue?
The trailing twelve month revenue for Integrated BioPharma is $43.9M.
-
What is Integrated BioPharma’s annual earnings per share (EPS)?
Integrated BioPharma’s EPS for 12 months was -$0.09.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process